drug protocol number

MRX-802

drug sponsor

Mirum Pharmaceuticals, Inc. / CTI

drug study

Maralixibat

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh).

drug status

Ongoing

drug phase